Overall N = 78,574 | Patients with prior mAb usea N = 26,656 | Patients without prior mAb usea n = 51,918 | |
---|---|---|---|
Demographics | |||
Age, mean (SD) | 46.7 (13.3) | 47.0 (12.8) | 46.5 (13.5) |
Female sex, n (%) | 68,631 (87.4%) | 23,319 (87.5%) | 45,312 (87.3%) |
Index payer type, n (%) | |||
Commercial | 50,607 (64.4%) | 17,002 (63.8%) | 33,605 (64.7%) |
Discounts/coupons | 16,118 (20.5%) | 5,234 (19.6%) | 10,884 (21.0%) |
Medicaid | 7,973 (10.2%) | 2,955 (11.1%) | 5,018 (9.7%) |
Cash | 2,997 (3.8%) | 1,134 (4.3%) | 1,863 (3.6%) |
Medicare | 873 (1.1%) | 329 (1.2%) | 544 (1.1%) |
Prescriber for index medication, n (%) | |||
Neurologist | 37,375 (47.6%) | 13,790 (51.7%) | 23,585 (45.4%) |
Nurse practitioner/ physician assistant | 23,915 (30.4%) | 8,553 (32.1%) | 15,362 (29.6%) |
Primary care physician | 11,719 (14.9%) | 2,401 (9.0%) | 9,318 (18.0%) |
Pain specialist | 1,194 (1.5%) | 479 (1.8%) | 715 (1.4%) |
Other | 4,371 (5.6%) | 1,433 (5.4%) | 2,938 (5.7%) |
Charlson comorbidity index score, n (%) | |||
0 | 57,871 (73.7%) | 19,770 (74.2%) | 38,101 (73.4%) |
1 | 12,356 (15.7%) | 4,174 (15.7%) | 8,182 (15.8%) |
2 | 5,062 (6.4%) | 1,665 (6.3%) | 3,397 (6.5%) |
3 + | 3,285 (4.2%) | 1,047 (3.9%) | 2,238 (4.3%) |
Most frequent comorbidities (> 5% of patients), n (%) | |||
Anxiety | 14,271 (18.2%) | 4,994 (18.7%) | 9,277 (17.9%) |
Hypertension | 13,792 (17.6%) | 4,538 (17.0%) | 9,254 (17.8%) |
Depression | 11,429 (14.6%) | 4,335 (16.3%) | 7.094 (13.7%) |
Asthma | 5,513 (7.0%) | 1,986 (7.5%) | 3,527 (6.8%) |